Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis
Summary
ICD Research's Hypermarcas SA : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Analysis contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers & acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about Hypermarcas SA
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Synopsis
Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.
This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.
The SWOT analysis identifies the company’s strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.
The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.
Reasons To Buy
Quickly enhance your understanding of Hypermarcas SA
Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
Increase business/sales activities by understanding your competitors’ businesses better.
Recognize potential partnerships and suppliers.
Key Highlights
Hypermarcas SA (Hypermarcas) is a manufacturer of pharmaceutical products. It primarily offers non-prescription (OTC) drugs, prescribed medications, branded, generics and sweeteners. The company markets its products under various brands including Addera D3, Alivium, Benegrip, Biotonico Fontoura, Doril, Engov, Epocler, Histamin, Lisador, Polaramine, Predsim, Rinosoro, Torsilax, Neo Química Zero-Cal, Finn and Adocyl. Its products are distributed directly to retailers through distributors and wholesalers across Brazil. The company operates through its subsidiary, Brainfarma Industria Quimica e Farmaceutica S.A. It operates distribution centers located in Anapolis and Goiania, Brazil. Hypermarcas is headquartered in Sao Paulo, Brazil.
- 1 Hypermarcas SA - Key Employees
- 2 Hypermarcas SA - Major Products and Services
- 3 Hypermarcas SA - History
- 4 Hypermarcas SA - Company Statement
- 5 Hypermarcas SA - Locations and Subsidiaries
- 5.1 Hypermarcas SA - Head Office
- 5.2 Hypermarcas SA - Other Locations and Subsidiaries
- 6 Hypermarcas SA - Business Analysis
- 6.1 Hypermarcas SA - Company Overview
- 6.2 Hypermarcas SA - Business Description
- 7 Hypermarcas SA - SWOT Analysis
- 7.1 Hypermarcas SA - SWOT Analysis - Overview
- 7.2 Hypermarcas SA - Strengths
- 7.2.1 Strength - Strengthening Liquidity Position
- 7.2.2 Strength - Strong Financial Performance
- 7.2.3 Strength - Diverse Brands and Product Portfolio
- 7.3 Hypermarcas SA - Weaknesses
- 7.3.1 Weakness - Overdependence on Brazilian market
- 7.4 Hypermarcas SA - Opportunities
- 7.4.1 Opportunity - New Product Launch
- 7.4.2 Opportunity - Growing Pharmaceutical Market
- 7.4.3 Opportunity - Business Reorganization
- 7.5 Hypermarcas SA - Threats
- 7.5.1 Threat - Declining Economy of Brazil
- 7.5.2 Threat - Competitive Landscape
- 7.5.3 Threat - Industry Regulations
- 8 Hypermarcas SA - Company Financial Analysis
- 8.1 Hypermarcas SA - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
- 9 Hypermarcas SA - Interim ratios
- 9.1.1 Hypermarcas SA - Financial ratios: Capital Market Ratios
- 9.2 Hypermarcas SA - Financial Performance and Ratio Charts
- 9.2.1 Hypermarcas SA - Revenue and Operating margin
- 9.2.2 Hypermarcas SA - Asset and Liabilities
- 9.2.3 Hypermarcas SA - Net Debt vs. Gearing Ratio
- 9.2.4 Hypermarcas SA - Operational Efficiency
- 9.2.5 Hypermarcas SA - Solvency
- 9.2.6 Hypermarcas SA - Valuation
- 9.3 Hypermarcas SA - Competitive Benchmarking
- 9.3.1 Hypermarcas SA - Market Capitalization
- 9.3.2 Hypermarcas SA - Efficiency
- 9.3.3 Hypermarcas SA - Valuation
- 9.3.4 Hypermarcas SA - Turnover: Inventory and Asset
- 9.3.5 Hypermarcas SA - Liquidity
- 10 Hypermarcas SA - Mergers & Acquisitions and Partnerships
- 10.1 Hypermarcas SA - M&A and Partnerships Strategy
- 11 Hypermarcas SA - Recent Developments
- 12 Appendix
- 12.1 Methodology
- 12.2 Hypermarcas SA - Ratio Definitions
- 12.3 Disclaimer
- List of Tables
- Table 1: Hypermarcas SA - Key Employees
- Table 2: Hypermarcas SA - Major Products and Services
- Table 3: Hypermarcas SA - History
- Table 4: Hypermarcas SA - Subsidiaries
- Table 5: Hypermarcas SA - Annual ratios
- Table 6: Hypermarcas SA - Interim ratios
- Table 7: Hypermarcas SA - Capital Market Ratios
- List of Figures
- Figure 1: Hypermarcas SA - Revenue and Operating Profit
- Figure 2: Hypermarcas SA - Asset and Liabilities
- Figure 3: Hypermarcas SA - Net Debt vs. Gearing Ratio
- Figure 4: Hypermarcas SA - Operational Efficiency
- Figure 5: Hypermarcas SA - Solvency
- Figure 6: Hypermarcas SA - Valuation
- Figure 7: Hypermarcas SA - Market Capitalization
- Figure 8: Hypermarcas SA - Efficiency
- Figure 9: Hypermarcas SA - Valuation
- Figure 10: Hypermarcas SA - Turnover: Inventory and Asset
- Figure 11: Hypermarcas SA - Liquidity
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook